首页 工具
登录
购物车

搜索结果

Search Results for " hdac in 3 "

如果没找到您满意的产品或者您对产品有其他要求,可以联系我们专业顾问为您提供针对性的合理建议。     QQ咨询       网站留言咨询

提交您的定制咨询

点击图片重新获取验证码
Cat. No. Product Name Target Signaling Pathways
T8508 HDAC-IN-3

GSK3117391A

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
HDAC-IN-3 (GSK3117391A)是组蛋白脱乙酰酶抑制剂,可治疗慢性炎症性疾病。
T24131 HDAC3-IN-T247

HDAC3 inhibitor T247,HDAC3 inhibitor-T247,HDAC3 IN T247,T247

Histone Demethylase; Antiviral Chromatin/Epigenetic; Immunology/Inflammation
HDAC3-IN-T247 (HDAC3 inhibitor T247) 是一种具有选择性和有效性的组蛋白去乙酰化酶 3HDAC3) 抑制剂,具有抗癌和抗病毒活性。HDAC3-IN-T247 以剂量依赖的方式诱导人结肠癌 HCT116 细胞中 NF-κB 乙酰化。HDAC3-IN-T247 抑制癌细胞增殖。
T39567 HDAC1/2-IN-3

HDAC1/2-IN-3

HDAC1/2-IN-3 is an inhibitor of both HDAC1 and HDAC2, demonstrating IC50 values of 0-5 nM and 5-10 nM, respectively.
T78880 Tubulin/HDAC-IN-3

Tubulin/HDAC-IN-3(compound 12a)为一种高效的tubulin/HDAC汇合型抑制剂,能显著破坏微管蛋白聚合(IC50: 5.4 μM),并对HDAC1/8展现强效抑制作用,IC50值分别为0.155 μM和0.177 μM。该化合物通过阻断细胞周期、诱导细胞凋亡(apoptosis)及抑制集落形成以施展其生物学效用。
T63529 HDAC/HSP90-IN-3

HDAC/HSP90-IN-3 是选择性的、有效的真菌 Hsp90 (IC50: 0.83 μM) 和 HDAC (IC50: 0.91 μM) 双重抑制剂,对耐唑白色念珠菌表现出抗真菌作用。HDAC/HSP90-IN-3 对重要毒力因子表现出抑制作用,能够下调耐药基因ERG11和CDR1。
T78906 CDK/HDAC-IN-3

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
CDK/HDAC-IN-3 是一种口服活性的 HDAC/CDK 双重抑制剂,对 CDK9、CDK12、CDK13HDAC1、HDAC2、HDAC3 表现出有效且选择性的抑制,IC50 值分别为 98.32 nM、98.85 nM、100 nM、62.12 nM、93.28 nM 和 82.87 nM。该化合物主要用于急性髓性白血病 (AML) 的相关研究。
T72777 c-Met/HDAC-IN-3

c-Met/HDAC-IN-3 是一种c-Met 和HDAC 抑制剂,对 c-Met 和HDAC1的IC50分别为 12.50 nM 和 26.97 nM。 c-Met/HDAC-IN-3 诱导凋亡(apoptosis),导致细胞周期阻滞在 G2/M 期。
T36575 HDAC3 Inhibitor

HDAC3 inhibitor is an allosteric inhibitor of histone deacetylase 3 (HDAC3; Ki = 0.16 nM). It is selective for HDAC3 over HDAC1 and HDAC2 (IC50s = 0.95, 11.81, and 95.45 nM, respectively, using recombinant HDACs). In addition, it is selective for acute myeloid, monocytic, and lymphoblastic leukemia cell lines (EC50s = 36.37, 76.64, and 151.7 nM, respectively) over chronic myeloid, acute promyelocytic, and acute lymphoblastic cells (EC50s = 2,160, >10,000, and >10,000 nM, respectively).
T24132 HDAC3-IN-T326

HDAC3 inhibitor-T326,T326,HDAC3 IN T326,HDAC3 inhibitor T326,HDAC3INT326

HDAC3-IN-T326 is a potent and selective HDAC3 inhibitor that acts by increasing NF-κB acetylation and activating HIV gene expression in latent HIV-infected cells.
T62786 HDAC1-IN-3

HDAC1-IN-3 是一种 Pf HDAC1 的有效抑制剂。HDAC1-IN-3 在野生型和耐多药寄生虫菌株中均具有抗疟作用。HDAC1-IN-3 对寄生虫所有生命周期表现出明显的体内杀伤效果。
T61139 HDAC6-IN-3

HDAC6-IN-3 (Compound 14) is a potent anti-prostate cancer agent that acts as an orally active inhibitor of HDAC6. It has IC50 values ranging from 0.02-1.54 μM for HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, and HDAC10. Additionally, HDAC6-IN-3 also demonstrates effective inhibition of MAO-A (IC50 = 0.79 μM) and LSD1 [1].
T79714 HDAC3-IN-2

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
HDAC3-IN-2 (compound 4i) 是一种具有纳摩尔级效力的吡嗪酰肼基HDAC3抑制剂,IC50值为14 nM,针对三阴性乳腺癌细胞表现出高效抑制作用。该化合物在细胞内毒性测定中显示,对4T1细胞株的IC50为0.55 μM,对MDA-MB-231细胞株的IC50为0.74 μM。HDAC3-IN-2通过增加乙酰化水平(如H3K9、H3K27和H4K12),促进细胞凋亡(涉及caspase-3、caspase-7和细胞色素c的水平提升),并抑制细胞增殖相关蛋白(如Bcl-2、CD44、EGFR和Ki-67)的表达,从而在荷瘤小鼠模型中表现出显著的体内抗肿瘤作用。
T61858 HDAC8-IN-3

HDAC8-IN-3 (compound P19) is a highly potent inhibitor of HDAC8, displaying an IC50 value of 9.3 μM and producing thermal stabilization. Moreover, HDAC8-IN-3 exhibits cytotoxicity and induces apoptosis specifically in leukemic cell lines [1].
T74003 HDAC3/6-IN-2

HDAC3/6-IN-2 (化合物 15) 是一种高效的HDAC6和HDAC3抑制剂,IC50值分别为0.368 μM和0.635 μM。此化合物不仅具备抗肿瘤活性,能够诱导癌细胞凋亡,同时通过降低HDAC6和HDAC3水平,与H3乙酰化和α-微管蛋白的上调有关。
T79713 JMJD3/HDAC-IN-1

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
JMJD3/HDAC-IN-1 (compound A5b) 是靶向 JMJD3HDAC1(IC50=16 nM)的双重抑制剂。它能够促进 H3K27 高甲基化和 H3K9 高乙酰化,并通过裂解 caspase-7 和 PARP 导致细胞凋亡。此外,JMJD3/HDAC-IN-1 对抑制癌细胞克隆形成、迁移和侵袭也表现出有效性。
T75018 HDAC6 degrader-3

HDAC6degrader-3 是一种有效的选择性 HDAC6降解剂,通过三元复合物形成和泛素-蛋白酶体途径,IC50值为 19.4 nM。HDAC6degrader-3HDAC6和 HDAC1的 IC50值分别为 4.54 nM 和 0.647 μM。HDAC6degrader-3 引起 α-微管蛋白的强烈高度乙酰化。
T62912 PI3K/HDAC-IN-2

PI3K/HDAC-IN-2 是一种有效的 PI3K/HDAC 双重抑制剂,能够作用于 PI3Kα (IC50: 226 nM)、PI3Kβ (IC50: 279 nM)、PI3Kγ (IC50: 467 nM)、PI3Kδ (IC50: 29 nM)、HDAC1 (IC50: 1.3 nM)、HDAC2 (IC50: 3.4 nM)、HDC4 (IC50: 973 nM)、HDAC6 (IC50: 17 nM)、HDAC8 (IC50: 12 nM)。PI3K/HDAC-IN-2 具有 PI3Kδ 和 I 类和 IIb 类 HDAC 选择性,并表现出显着的抗癌作用。
T79710 PI3Kα/HDAC6-IN-1

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
PI3Kα/HDAC6-IN-1(化合物21j)是一种针对PI3Kα/HDAC6的双重抑制剂,其IC50值分别为2.9 nM和26 nM。该化合物还能抑制AKT(Ser473)的磷酸化,诱导α-微管蛋白的积累,并促进其乙酰化,但对乙酰化组蛋白H3和H4无显著影响。在L-363细胞系中,PI3Kα/HDAC6-IN-1显示了高效的抑制活性(IC50=0.17 μM),表现出良好的抗癌潜力。
T2025 HDAC-IN-7

HBI-8000,西达本胺杂质,CS055,Chidamide impurity

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
HDAC-IN-7 (HBI-8000) 是 Chidamide 的一种杂质。Chidamide 是一种可口服的 HDAC 酶 I 类 HDAC1/2/3 和 IIb 类 HDAC10 抑制剂。
T2078 Fimepinostat

CUDC-907,PI3K/HDAC Inhibitor,CUDC 907

Apoptosis; PI3K; HDAC Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair; PI3K/Akt/mTOR signaling
Fimepinostat (CUDC 907) 是一种 I 型PI3K 及 I 和 II 型HDAC 酶抑制剂,作用于 PI3Kα/PI3Kβ/PI3Kδ 和 HDAC1/HDAC2/HDAC3/HDAC10 ,IC50分别为 19/54/39 nM 和 1.7/5.0/1.8/2.8 nM。
T9041 AES-350

Apoptosis; HDAC Apoptosis; Chromatin/Epigenetic; DNA Damage/DNA Repair
AES-350 是一种具有口服活性HDAC6抑制剂,IC50和Ki 分别为 0.0244 μM 和 0.035 μM。它对 HDAC3、8 和 11 的 IC50值分别为 0.187、0.245和大于1μM。它通过抑制 HDAC 诱导 AML 细胞凋亡,可研究急性髓系白血病。
T6865 Quisinostat dihydrochloride

Quisinostat 2HCl,Quisinostat (JNJ-26481585) 2HCl,JNJ26854165(Quisinostat) 2HCl,JNJ-26481585 2HCl

Apoptosis; HDAC; Autophagy Apoptosis; Autophagy; Chromatin/Epigenetic; DNA Damage/DNA Repair
Quisinostat dihydrochloride (JNJ26854165(Quisinostat) 2HCl) 是一种有口服活性,高效的 pan-HDAC 抑制剂,具有广泛的抗肿瘤活性。它对 HDAC1、HDAC2、HDAC4、HDAC10和HDAC11 的IC50值分别为 0.11 nM、0.33 nM、0.64 nM、0.46 nM 和 0.37 nM。
T62545 HDAC-IN-43

HDAC-IN-43 是一种强效的 HDAC 1/3/6 抑制剂,对 HDAC 1、HDAC 3HDAC 6 的 IC50 值分别为 82 nM、45 nM 和 24 nM。HDAC-IN-43 是一种弱的 PI3K/mTOR 抑制剂,对 PI3K 和 mTOR 的 IC50 值分别为 3.6 μM 和 3.7 μM。HDAC-IN-43 具有广谱的抗增殖效果。
T62920 HDAC-IN-38

HDAC-IN-38 是一种 HDAC 的有效抑制剂。HDAC-IN-38 对 HDAC1、2、3、5、6 和 8 具有类似的微摩尔抑制作用,也可以提高组蛋白乙酰化水平 (H3K14 或 H4K5)。HDAC-IN-38 能够提高脑血流量 (CBF),减轻认知障碍,改善海马萎缩。
T13792 Nampt-IN-3

Others Others
Nampt-IN-3 simultaneously inhibit nicotinamide phosphoribosyltransferase (NAMPT) and HDAC (IC50s of 31 nM and 55 nM, respectively).
T61209 HDAC-IN-27

HDAC-IN-27 是一种有效的口服活性HDACI 类选择性抑制剂,对 HDAC1-3 的 IC50值范围为 0.433.01 nM。抗急性髓系白血病 (AML) 活性。
T62072 HDAC-IN-47

HDAC-IN-47 是一种口服具有活力的组蛋白去乙酰化酶 (HDAC) 的抑制剂,对 HDAC1、HDAC2、HDAC3HDAC6、HDAC8 的 IC50 值分别为 19.75 nM、57.8 nM、40.27 nM、5.63 nM、302.73 nM。HDAC-IN-47 可以将细胞周期阻滞在 G2/M 期,抑制细胞自噬,能够利用 Bax/Bcl-2 和 caspase-3 通路诱导凋亡,在体内具有抗癌活性。
T35765 SAHA-BPyne

Suberoylanilide hydroxamic acid (SAHA) is a class I and class II histone deacetylase (HDAC) inhibitor that binds directly to the catalytic site of the enzyme thereby blocking substrate access. SAHA-BPyne is a SAHA derivative with a benzophenone crosslinker and an alkyne tag intended to be used for profiling HDAC activities in proteomes and live cells. Such terminal alkyne groups can be used in linking reactions, known as click chemistry, characterized by high dependability and specificity of azi...
T74783 HDAC-IN-53

HDAC Chromatin/Epigenetic; DNA Damage/DNA Repair
HDAC-IN-53是一种口服活性的选择性HDAC1-3抑制剂,其IC50分别为47 nM、125 nM和450 nM。该化合物不针对II类HDAC(HDAC4、5、6、7、9;IC50>10 μM)展现抑制作用。HDAC-IN-53能够诱导caspase依赖的细胞凋亡并在裸鼠中显著抑制人肿瘤异种移植物生长,同时抑制携带MC38结肠癌的免疫活性小鼠的肿瘤发展。
T21898 MI-192

MI-192 是一种选择性 HDAC2和 HDAC3抑制剂,IC50分别为 30 nM 和 16 nM。MI-192 比其他 HDAC 异构体对 HDAC2/3 具有更高选择性。MI-192 诱导髓系白血病细胞凋亡 (apoptosis)。抗癌和神经保护活性。
T79683 HDAC/CD13-IN-1

Others Others
HDAC/CD13-IN-1 (Compound 12) 作为HDAC/CD13抑制剂, 对hCD13的IC50为0.34 μM, 猪CD13为0.53 μM, 对HDAC1/2/3的IC50分别为0.03、0.06、0.02 μM。此化合物有效抑制MV4-11、K562、Jeko-1 和 HL60细胞增殖, IC50范围为0.25-2.04 μM,并诱导癌细胞凋亡。同时表现出抗转移和抗侵袭的特性。
T70962 MHY219

MHY219 is a novel HDAC inhibitor. MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells. MHY219 was shown to enhance the cytotoxicity on DU145 cells (IC50, 0.36 μM) when compared with LNCaP (IC50, 0.97 μM) and PC3 cells (IC50, 5.12 μM). MHY219 showed a potent inhibition of total HDAC activity when compared with SAHA. MHY219 increased histone H3 hyperacetylation and reduced the expression of class I HDACs (1, 2 and 3) in prostate cancer cells. M...
T35822 CAY10722

CAY10722 is an inhibitor of sirtuin 3 (SIRT3), a class III HDAC (71% inhibition at 200 μM). SIRT3 is involved in modulating metabolic homeostasis as a NAD+-dependent protein deacetylase in the mitochondria. SIRT3 functions as either an oncogene or tumor suppressor, depending on cancer cell type. High SIRT3 expression in patient-derived esophageal cancer tissues is associated with shorter survival and, in mice, downregulation leads to a lower tumor load. In contrast, low SIRT3 expression in patie...
T61753 MPT0G211 mesylate

MPT0G211 mesylate is a powerful and selective HDAC6 inhibitor (IC50 = 0.291 nM), with high oral bioavailability. It exhibits remarkable selectivity for HDAC6 over other HDAC isoforms (>1000-fold selectivity). Additionally, MPT0G211 mesylate can effectively cross the blood-brain barrier. In preclinical studies using an Alzheimer's disease model, MPT0G211 mesylate has shown promising results in reducing tau phosphorylation and cognitive deficits. Furthermore, this compound exhibits anti-metastatic...
T36629 Givinostat

Givinostat (ITF-2357) is a HDAC inhibitor with an IC50 of 198 and 157 nM for HDAC1 and HDAC3, respectively. Givinostat (ITF2357) suppresses total LPS-induced IL-1β production robustly compared with the reduction by ITF3056. At 25, 50, and 100 nM, Givinostat reduced IL-1β secretion more than 70%. Givinostat (ITF-2357) suppresses the production of IL-6 in PBMCs stimulated with TLR agonists as well as the combination of IL-12 plus IL-18. IL-6 secretion decreases to 50% at 50 nM Givinostat, but at 1...

化合物

HDAC-IN-3
Cat.No: T8508
Synonym: GSK3117391A
Target: HDAC
HDAC3-IN-T247
Cat.No: T24131
Synonym: HDAC3 inhibitor T247,HDAC3 inhibitor-T247,HDAC3 IN T247,T247
Target: Histone Demethylase, Antiviral
HDAC1/2-IN-3
Cat.No: T39567
Synonym: HDAC1/2-IN-3
Target:
Tubulin/HDAC-IN-3
Cat.No: T78880
Synonym:
Target:
HDAC/HSP90-IN-3
Cat.No: T63529
Synonym:
Target:
CDK/HDAC-IN-3
Cat.No: T78906
Synonym:
Target: HDAC
c-Met/HDAC-IN-3
Cat.No: T72777
Synonym:
Target:
HDAC3 Inhibitor
Cat.No: T36575
Synonym:
Target:
HDAC3-IN-T326
Cat.No: T24132
Synonym: HDAC3 inhibitor-T326,T326,HDAC3 IN T326,HDAC3 inhibitor T326,HDAC3INT326
Target:
HDAC1-IN-3
Cat.No: T62786
Synonym:
Target:
HDAC6-IN-3
Cat.No: T61139
Synonym:
Target:
HDAC3-IN-2
Cat.No: T79714
Synonym:
Target: HDAC
HDAC8-IN-3
Cat.No: T61858
Synonym:
Target:
HDAC3/6-IN-2
Cat.No: T74003
Synonym:
Target:
JMJD3/HDAC-IN-1
Cat.No: T79713
Synonym:
Target: HDAC
HDAC6 degrader-3
Cat.No: T75018
Synonym:
Target:
PI3K/HDAC-IN-2
Cat.No: T62912
Synonym:
Target:
PI3Kα/HDAC6-IN-1
Cat.No: T79710
Synonym:
Target: HDAC
HDAC-IN-7
Cat.No: T2025
Synonym: HBI-8000,西达本胺杂质,CS055,Chidamide impurity
Target: HDAC
Fimepinostat
Cat.No: T2078
Synonym: CUDC-907,PI3K/HDAC Inhibitor,CUDC 907
Target: Apoptosis, PI3K, HDAC
AES-350
Cat.No: T9041
Synonym:
Target: Apoptosis, HDAC
Quisinostat dihydrochloride
Cat.No: T6865
Synonym: Quisinostat 2HCl,Quisinostat (JNJ-26481585) 2HCl,JNJ26854165(Quisinostat) 2HCl,JNJ-26481585 2HCl
Target: Apoptosis, HDAC, Autophagy
HDAC-IN-43
Cat.No: T62545
Synonym:
Target:
HDAC-IN-38
Cat.No: T62920
Synonym:
Target:
Nampt-IN-3
Cat.No: T13792
Synonym:
Target: Others
HDAC-IN-27
Cat.No: T61209
Synonym:
Target:
HDAC-IN-47
Cat.No: T62072
Synonym:
Target:
SAHA-BPyne
Cat.No: T35765
Synonym:
Target:
HDAC-IN-53
Cat.No: T74783
Synonym:
Target: HDAC
MI-192
Cat.No: T21898
Synonym:
Target:
HDAC/CD13-IN-1
Cat.No: T79683
Synonym:
Target: Others
MHY219
Cat.No: T70962
Synonym:
Target:
CAY10722
Cat.No: T35822
Synonym:
Target:
MPT0G211 mesylate
Cat.No: T61753
Synonym:
Target:
Givinostat
Cat.No: T36629
Synonym:
Target:
TargetMol Loading
联系我们
400-820-0310

上海市静安区江场三路238号8楼